What You Should Know
- Global connected diabetes care leader Glooko, Inc. announced GestationalCare™, a dedicated pregnancy-specific clinical module built on its ambulatory diabetes management platform.
- GestationalCare resolves the acute challenge of compressed clinical timelines in pregnancy, replacing disconnected spreadsheets, patient portal screenshots, and paper logs with automated, device-neutral data aggregation.
- Covers the full spectrum of maternal metabolic care: Gestational Diabetes Mellitus (GDM), Type 2 diabetes in pregnancy, and Type 1 diabetes throughout pregnancy.
- Available immediately to healthcare organizations in the United Kingdom, with general availability in the United States scheduled for October 2026.
How Glooko’s Pregnancy-Specific Module Automates MFM and OB/GYN Glycemic Triage
Managing diabetes during pregnancy operates on a compressed clinical clock: hormonal shifts can alter insulin sensitivity within days, while glycemic volatility poses immediate risks for both maternal and fetal outcomes. Despite the need for rapid intervention, prenatal glycemic tracking often relies on disconnected paper logs, patient portal photos of glucometer screens, manual spreadsheets, and unintegrated continuous glucose monitor (CGM) downloads.
When care teams must spend time manually reconstructing a patient’s glycemic history from fragmented records, clinical adjustments are delayed and rising-risk individuals can slip through the cracks between routine prenatal visits. To standardize glycemic tracking across maternal health teams, global digital health platform Glooko has launched GestationalCare™, a specialized pregnancy module within its ambulatory diabetes management platform.
Structuring the Pregnancy-Specific Glycemic Workflow
GestationalCare adapts Glooko’s device-neutral connectivity to create a unified clinical workflow for maternal-fetal medicine specialists, OB/GYNs, endocrinologists, certified diabetes educators, and nursing teams. The module supports glycemic tracking across gestational diabetes mellitus (GDM), Type 2 diabetes in pregnancy, and pre-existing Type 1 diabetes.
Key capabilities embedded in the module include:
- Population-Level Risk Prioritization: Surfaces at-risk individuals across an entire clinic population by flagging persistent fasting hyperglycemia, postprandial spikes, and gaps in patient data submissions.
- Contextual Glycemic Pattern Review: Visualizes blood glucose readings against clinical pregnancy targets across fasting and mealtime intervals, presenting nutritional logs, medication doses, and device telemetry in a single view.
- Between-Visit Engagement: Facilitates continuous touchpoints through the patient-facing Glooko Mobile App—including automated Bluetooth device syncing, mobile meal logging, structured educational modules, and secure clinical communication.
- Postpartum Transition Tracking: Maintains continuity of care through the postpartum period to monitor glycemic normalization and transition patients into ongoing primary or endocrine care.
Rollout and Availability
GestationalCare is available immediately to healthcare providers in the United Kingdom and is scheduled to launch for U.S. health systems and ambulatory practices in October 2026.
